澳大利亚新南威尔士州的救护服务陷入设备危机。该州投入5500万澳元部署的Corpuls除颤器在2025年已录得1229次故障，占目前运营的1500台设备总数的八成以上[1]。医疗监管机构澳大利亚医疗用品管理局已暂停Corpuls设备的注册[1]，尽管暂停的具体原因未被公开披露。
NSW救护服务的临床实践副主任Marty Nichols在内部论坛表达了明确的不满，称"I am not happy with the corpuls"[1]。故障问题的严重程度令人担忧——在一次单独事件中，除颤器警报甚至响起了135次[1]。鉴于这些失效，NSW救护车已被强制继续携带早前计划淘汰的旧型LifePak设备作为备用[1]。
该州政府在2022年启动了Corpuls计划以替换这批老设备，投入5500万澳元进行设备更新[1]。该项目的总成本超5000万澳元[1]，Corpuls设备原定使用至少5年[1]。
A senior paramedic has voiced sharp criticism over the performance of Corpuls defibrillators deployed across New South Wales ambulances, citing a staggering failure rate that has undermined a major government investment. The clinical practice director of NSW Ambulance Service, Marty Nichols, stated in an internal forum that he is "not happy with the corpuls," as the state's fleet of 1,500 devices has recorded 1,229 malfunctions throughout 2025 [1]. The equipment rollout, which cost the NSW government over 50 million Australian dollars and was initiated in 2022 to replace outdated LifePak models, has proven far more problematic than anticipated [1].
The failures have become severe enough to force a reversal of operational protocols. Ambulances in NSW are now mandated to carry the older LifePak defibrillators as backup devices, undermining the original modernization objective [1]. One documented incident captured a defibrillator alarm sounding 135 times during a single event, exemplifying the extent of the technical malfunctions [1]. The devices were intended to remain in service for at least five years [1].
Regulatory action has followed the mounting problems. Australia's Therapeutic Goods Administration (TGA) has suspended the registration of Corpuls 3 and Corpuls 3T defibrillators, though the specific grounds for suspension have not been publicly disclosed [1].